Development and Validation of a Combined Glycolysis and Immune Prognostic Model for Melanoma.
Front Immunol
; 12: 711145, 2021.
Article
in En
| MEDLINE
| ID: mdl-34659201
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Glycolysis
/
Melanoma
Type of study:
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
Front Immunol
Year:
2021
Document type:
Article
Country of publication: